Company Valuation: eFFECTOR Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023
Market Cap 1 334.3 17.91 30.2
Change - -94.64% 68.61%
Enterprise Value (EV) 1 304.6 11.88 32.38
Change - -96.1% 172.45%
P/E 18.8x -0.78x -0.71x
PBR 19.3x 4.58x -6.01x
PEG 0x 0x -0x
Capitalization / Revenue 233,760,757x 5,041,796x -
EV / Revenue - - -
EV / EBITDA -9.56x -0.37x -0.96x
EV / EBIT -9.55x -0.37x -0.96x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 11 -13.76 -16.37
Distribution rate - - -
Net sales 1.43 3.553 -
EBITDA 1 -31.87 -32.35 -33.73
EBIT 1 -31.9 -32.4 -33.84
Net income 1 15.8 -22.66 -35.81
Net Debt 1 -29.67 -6.029 2.175
Reference price 2 207.000000 10.690000 11.685000
Nbr of stocks (in thousands) 1,615 1,676 2,585
Announcement Date 3/16/22 3/8/23 3/26/24
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 3.76K
19.64x6.93x13.92x1.51% 66.93B
31.94x9.24x44.54x0.04% 61.97B
-79.21x15.29x-73.77x-.--% 28.26B
28.46x6.03x15.64x-.--% 24.59B
-14.63x5.3x-6.66x-.--% 24.3B
26.45x4.98x16.56x-.--% 19.41B
48.28x17.79x36.09x0.31% 16.77B
1225.47x35.26x769.42x-.--% 14.18B
-15x3382.33x-17.29x-.--% 14B
Average 141.27x 387.02x 88.72x 0.21% 27.04B
Weighted average by Cap. 73.54x 184.88x 49.64x 0.4%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. EFTR Stock
  4. Valuation eFFECTOR Therapeutics, Inc.
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!